EICHORCondition: Healthy · Sponsor: Merck Sharp & Dohme LLC
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
Epstein Barr virus (EBV) is a virus which can cause infectious mononucleosis and is associated with certain kinds of cancer and multiple sclerosis. Researchers are looking for new ways to prevent disease related to EBV and have developed a new study vaccine (V350A and V350B). The main goal of this study is to learn about the safety and tolerability of V350A and V350B in healthy adults.
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: The key inclusion criteria include but are not limited to the following: * Is in good health before randomization. * Has a body mass index between 18 and 38 kg/m\^2, inclusive, for adults 18-30; has a body mass index between 15 and 38 kg/m\^2, inclusive, for adolescents 12-17. Exclusion Criteria: The key exclusion criteria include but are not limited to the following: * Has a confirmed or suspected case of infectious mononucleosis within 12 months prior to enrollment. * Has any immunosuppressive medical condition or receive any immunosuppressive therapy.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| California Clinical Trials Medical Group managed by PAREXEL ( Site 0011) | Glendale, California, United States | Completed |
| QPS-MRA, LLC ( Site 0012) | South Miami, Florida, United States | Active Not Recruiting |
| Alliance for Multispecialty Research, LLC ( Site 0008) | Kansas City, Missouri, United States | Recruiting |
| Bio-Kinetic Clinical Applications, LLC dba QPS-MO ( Site 0016) | Springfield, Missouri, United States | Recruiting |
| Velocity Clinical Research Lincoln ( Site 0004) | Lincoln, Nebraska, United States | Recruiting |
| Velocity Clinical Research, Omaha ( Site 0005) | Omaha, Nebraska, United States | Recruiting |
| Remington-Davis, Inc. ( Site 0017) | Columbus, Ohio, United States | Recruiting |
| Lynn Health Science Institute ( Site 0010) | Oklahoma City, Oklahoma, United States | Recruiting |
| Alliance for Multispecialty Research, LLC ( Site 0009) | Knoxville, Tennessee, United States | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06655324